Steube K, Gross V, Häussinger D, Tran-Thi T A, Decker K, Gerok W, Heinrich P C
Biochem Biophys Res Commun. 1986 Dec 30;141(3):949-55. doi: 10.1016/s0006-291x(86)80135-8.
The clearance of the rat acute-phase proteins alpha 2-macroglobulin, alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein with no, high-mannose, hybrid or complex type oligosaccharide side chains was determined in the isolated perfused rat liver. The differently glycosylated forms of the three proteins were obtained from rat hepatocyte primary cultures treated with different inhibitors of glycosylation. The complex type forms of the three proteins were essentially not cleared by the liver during 2 h of perfusion. Unglycosylated alpha 2-macroglobulin and alpha 1-acid glycoprotein decreased in the perfusate by about 50% after 2 h; unglycosylated alpha 1-proteinase inhibitor was not taken up by the liver. The high-mannose type forms of the three proteins were nearly totally cleared. After 2 h of perfusion 10%, 45% and 30% of the hybrid type forms of alpha 2-macroglobulin, alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein, respectively, were cleared. The clearance rates of high-mannose and of hybrid type glycoproteins could be reduced to the rates of complex type glycoproteins by the addition of mannan to the perfusate. It is concluded that complex type glycosylation prevents the uptake of plasma glycoproteins by the liver.
在离体灌注大鼠肝脏中测定了大鼠急性期蛋白α2-巨球蛋白、α1-蛋白酶抑制剂和α1-酸性糖蛋白的清除情况,这些蛋白带有无、高甘露糖、杂合或复合型寡糖侧链。这三种蛋白的不同糖基化形式是从用不同糖基化抑制剂处理的大鼠肝细胞原代培养物中获得的。在灌注2小时期间,这三种蛋白的复合型形式基本上未被肝脏清除。未糖基化的α2-巨球蛋白和α1-酸性糖蛋白在灌注2小时后,灌注液中的含量下降了约50%;未糖基化的α1-蛋白酶抑制剂未被肝脏摄取。这三种蛋白的高甘露糖型形式几乎被完全清除。灌注2小时后,α2-巨球蛋白、α1-蛋白酶抑制剂和α1-酸性糖蛋白的杂合型形式分别有10%、45%和30%被清除。通过向灌注液中添加甘露聚糖,高甘露糖型和杂合型糖蛋白的清除率可降低至复合型糖蛋白的清除率。结论是复合型糖基化可防止肝脏摄取血浆糖蛋白。